Volumetric Bone Mineral Density and it's Relationship With Osteoporotic Fractures in Parkinson's Disease
NCT ID: NCT03095690
Last Updated: 2018-03-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
90 participants
INTERVENTIONAL
2016-01-07
2017-06-21
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of Factors Associated With the Volumetric and Areal Bone Mineral Density and Bone Strength in Parkinson's Disease
NCT02930512
Resting-state Imaging and OSteoporosiS
NCT07030205
Osteoporosis and Knee Insufficiency Fracture
NCT02332681
Radiological Biological Genetic and Micro-architectural Bone Determinants of Fractures in Men With Low Bone Mineral Density
NCT01250314
Texture Analysis for Postmenopausal Osteoporosis
NCT00145977
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Idiopathic Parkinson's Disease patients
High resolution peripheral scanner (HRpQCT).
High resolution peripheral scanner (HRpQCT).
radius and tibia osteodensitometry measurement
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
High resolution peripheral scanner (HRpQCT).
radius and tibia osteodensitometry measurement
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Parkinson's disease of moderate severity (Index HOEHN and Yahr \<5)
* Patient can respond to questionnaires, with or without help
Exclusion Criteria
* Severe Parkinson's disease (Index HOEHN and Yahr ≥5 )
* Heavy-morbidity including heart failure NYHA\> 3 or chronic respiratory failure, terminal or severe renal impairment known dialyzed
* Pregnancy
35 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Régional d'Orléans
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eric LESPESSAILLES, Ph
Role: PRINCIPAL_INVESTIGATOR
CHR d'ORLEANS
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHR d'ORLEANS
Orléans, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CHRO-2015-05
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.